Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

Laryngomalacia and Swallow Dysfunction.

Scott BL, Lam D, MacArthur C.

Ear Nose Throat J. 2019 May 23:145561319847459. doi: 10.1177/0145561319847459. [Epub ahead of print]

PMID:
31119989
2.

Oxidation of uranium(iv) mixed imido-amido complexes with PhEEPh and to generate uranium(vi) bis(imido) dichalcogenolates, U(NR)2(EPh)2(L)2.

Tomson NC, Anderson NH, Tondreau AM, Scott BL, Boncella JM.

Dalton Trans. 2019 May 3. doi: 10.1039/c9dt00680j. [Epub ahead of print]

PMID:
31049520
3.

Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis.

Salit RB, Scott BL, Stevens EA, Baker KK, Gooley TA, Deeg HJ.

Bone Marrow Transplant. 2019 Apr 8. doi: 10.1038/s41409-019-0523-3. [Epub ahead of print]

PMID:
30962501
4.

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.

Cooper JP, Khajaviyan S, Smith SD, Maloney DG, Shustov AR, Warren EH, Soma LA, Lynch RC, Ujjani C, Till B, Halpern AB, Gopal AK, Deeg HJ, Scott BL, Shadman M.

Clin Lymphoma Myeloma Leuk. 2019 Mar 11. pii: S2152-2650(19)30124-7. doi: 10.1016/j.clml.2019.03.003. [Epub ahead of print]

PMID:
30948330
5.

Encapsulated Sinonasal Schwannoma.

Scott BL, Van Sandt M, Loyo M.

Ear Nose Throat J. 2019 Apr-May;98(4):205-206. doi: 10.1177/0145561318823321. Epub 2019 Mar 5. No abstract available.

PMID:
30836787
6.

Complexation of High-Valency Mid-Actinides by a Lipophilic Schiff Base Ligand: Synthesis, Structural Characterization, and Progress toward Selective Extraction.

Bustillos CG, Hawkins CA, Copping R, Reilly SD, Scott BL, May I, Nilsson M.

Inorg Chem. 2019 Mar 18;58(6):3559-3563. doi: 10.1021/acs.inorgchem.8b02849. Epub 2019 Feb 26.

PMID:
30807118
7.

Different Munc18 proteins mediate baseline and stimulated airway mucin secretion.

Jaramillo AM, Piccotti L, Velasco WV, Delgado ASH, Azzegagh Z, Chung F, Nazeer U, Farooq J, Brenner J, Parker-Thornburg J, Scott BL, Evans CM, Adachi R, Burns AR, Kreda SM, Tuvim MJ, Dickey BF.

JCI Insight. 2019 Mar 21;4(6). pii: 124815. doi: 10.1172/jci.insight.124815. eCollection 2019 Mar 21.

8.

Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.

Cooper JP, Farah RJ, Stevenson PA, Gooley TA, Storb R, Scott BL.

Biol Blood Marrow Transplant. 2019 Feb 1. pii: S1083-8791(19)30091-6. doi: 10.1016/j.bbmt.2019.01.033. [Epub ahead of print]

PMID:
30711779
9.

Linked Picolinamide Nickel Complexes as Redox Carriers for Nonaqueous Flow Batteries.

Chu T, Popov IA, Andrade GA, Maurya S, Yang P, Batista ER, Scott BL, Mukundan R, Davis BL.

ChemSusChem. 2019 Apr 5;12(7):1304-1309. doi: 10.1002/cssc.201802985. Epub 2019 Feb 7.

PMID:
30675995
10.

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.

Monaco F, Scott BL, Chauncey TR, Petersen FB, Storer BE, Baron F, Flowers ME, Deeg HJ, Maloney DG, Storb R, Sandmaier BM.

Haematologica. 2019 Jun;104(6):1221-1229. doi: 10.3324/haematol.2018.199398. Epub 2019 Jan 10.

11.

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.

Halpern AB, Othus M, Huebner EM, Scott BL, Hendrie PC, Percival MM, Becker PS, Smith HA, Oehler VG, Orozco JJ, Cassaday RD, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Estey EH, Walter RB.

Haematologica. 2019 Apr;104(4):e143-e146. doi: 10.3324/haematol.2018.204792. Epub 2018 Nov 8. No abstract available.

12.

Plutonium coordination and redox chemistry with the CyMe4-BTPhen polydentate N-donor extractant ligand.

Reilly SD, Su J, Keith JM, Yang P, Batista ER, Gaunt AJ, Harwood LM, Hudson MJ, Lewis FW, Scott BL, Sharrad CA, Whittaker DM.

Chem Commun (Camb). 2018 Nov 18;54(89):12582-12585. doi: 10.1039/c8cc06015k. Epub 2018 Oct 23.

PMID:
30349920
13.

A sulphur and uranium fiesta! Synthesis, structure, and characterization of neutral terminal uranium(vi) monosulphide, uranium(vi) η2-disulphide, and uranium(iv) phosphine sulphide complexes.

Pagano JK, Arney DSJ, Scott BL, Morris DE, Kiplinger JL, Burns CJ.

Dalton Trans. 2018 Dec 18;48(1):50-57. doi: 10.1039/c8dt02932f.

PMID:
30280177
14.

Crystal structure and redox potentials of the tppz-bridged {RuCl(bpy)}+ dimer.

Rein FN, Chen W, Scott BL, Rocha RC.

Acta Crystallogr E Crystallogr Commun. 2018 Aug 16;74(Pt 9):1250-1253. doi: 10.1107/S2056989018011258. eCollection 2018 Sep 1.

15.

Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD.

Rashidi A, Shanley R, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Bone Marrow Transplant. 2019 Mar;54(3):490-493. doi: 10.1038/s41409-018-0331-1. Epub 2018 Aug 31. No abstract available.

PMID:
30171221
16.

A series of dithiocarbamates for americium, curium, and californium.

Cary SK, Su J, Galley SS, Albrecht-Schmitt TE, Batista ER, Ferrier MG, Kozimor SA, Mocko V, Scott BL, Van Alstine CE, White FD, Yang P.

Dalton Trans. 2018 Oct 23;47(41):14452-14461. doi: 10.1039/c8dt02658k.

PMID:
30168828
17.

It's Not All in the Conditioning or the Perils of Early Trial Cessation.

Scott BL.

Biol Blood Marrow Transplant. 2018 Oct;24(10):1957-1958. doi: 10.1016/j.bbmt.2018.08.014. Epub 2018 Aug 18. No abstract available.

PMID:
30125667
18.

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia.

Garcia-Manero G, Scott BL, Cogle CR, Boyd TE, Kambhampati S, Hetzer J, Dong Q, Kumar K, Ukrainskyj SM, Beach CL, Skikne BS.

Leuk Res. 2018 Sep;72:79-85. doi: 10.1016/j.leukres.2018.08.001. Epub 2018 Aug 3.

19.

FRETting about the affinity of bimolecular protein-protein interactions.

Lin T, Scott BL, Hoppe AD, Chakravarty S.

Protein Sci. 2018 Oct;27(10):1850-1856. doi: 10.1002/pro.3482.

PMID:
30052312
20.

Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States.

Ma X, Steensma DP, Scott BL, Kiselev P, Sugrue MM, Swern AS.

BMJ Open. 2018 Jul 23;8(7):e019955. doi: 10.1136/bmjopen-2017-019955.

21.

Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.

Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Br J Haematol. 2018 Sep;182(6):887-894. doi: 10.1111/bjh.15492. Epub 2018 Jul 13.

PMID:
30004111
22.

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.

de Lima M, Oran B, Champlin RE, Papadopoulos EB, Giralt SA, Scott BL, William BM, Hetzer J, Laille E, Hubbell B, Skikne BS, Craddock C.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2017-2024. doi: 10.1016/j.bbmt.2018.06.016. Epub 2018 Jun 20.

23.

Identification of the Formal +2 Oxidation State of Neptunium: Synthesis and Structural Characterization of {NpII[C5H3(SiMe3)2]3}1.

Su J, Windorff CJ, Batista ER, Evans WJ, Gaunt AJ, Janicke MT, Kozimor SA, Scott BL, Woen DH, Yang P.

J Am Chem Soc. 2018 Jun 20;140(24):7425-7428. doi: 10.1021/jacs.8b03907. Epub 2018 Jun 5.

PMID:
29870238
24.

Cs[Tf2N]: a second polymorph with a layered structure.

Stritzinger JT, Droessler JE, Scott BL, Goff GS.

Acta Crystallogr E Crystallogr Commun. 2018 Mar 23;74(Pt 4):551-554. doi: 10.1107/S2056989018004401. eCollection 2018 Apr 1.

25.

The multidisciplinary tumor board for the management of cutaneous neoplasms: A national survey of academic medical centers.

Scott BL, Srivastava D, Nijhawan RI.

J Am Acad Dermatol. 2018 Jun;78(6):1216-1218.e3. doi: 10.1016/j.jaad.2016.12.029. No abstract available.

PMID:
29754889
26.

Non-aqueous neptunium and plutonium redox behaviour in THF - access to a rare Np(iii) synthetic precursor.

Pattenaude SA, Anderson NH, Bart SC, Gaunt AJ, Scott BL.

Chem Commun (Camb). 2018 Jun 12;54(48):6113-6116. doi: 10.1039/c8cc02611d.

PMID:
29736543
27.

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.

Halpern AB, Othus M, Huebner EM, Scott BL, Becker PS, Percival MM, Hendrie PC, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Appelbaum FR, Erba HP, Estey EH, Walter RB.

Leukemia. 2018 Nov;32(11):2352-2362. doi: 10.1038/s41375-018-0135-8. Epub 2018 Apr 17.

28.

Histoplasmosis Myocarditis in an Immunocompetent Host After a Recreational Mud Run.

Scott BL, Sherwin JI, Rehder KJ, Campbell MJ, Ozment CP.

Pediatrics. 2018 Apr;141(Suppl 5):S462-S465. doi: 10.1542/peds.2017-1074.

29.

Advancing Understanding of the +4 Metal Extractant Thenoyltrifluoroacetonate (TTA-); Synthesis and Structure of MIVTTA4 (MIV = Zr, Hf, Ce, Th, U, Np, Pu) and MIII(TTA)4- (MIII = Ce, Nd, Sm, Yb).

Cary SK, Livshits M, Cross JN, Ferrier MG, Mocko V, Stein BW, Kozimor SA, Scott BL, Rack JJ.

Inorg Chem. 2018 Apr 2;57(7):3782-3797. doi: 10.1021/acs.inorgchem.7b03089. Epub 2018 Mar 21.

PMID:
29561140
30.

Allogeneic transplantation for myelofibrosis with adverse risk karyotype: Attack on the clones?

Cooper JP, Scott BL.

Am J Hematol. 2018 May;93(5):603-604. doi: 10.1002/ajh.25078. Epub 2018 Mar 30. No abstract available.

31.

Membrane bending occurs at all stages of clathrin-coat assembly and defines endocytic dynamics.

Scott BL, Sochacki KA, Low-Nam ST, Bailey EM, Luu Q, Hor A, Dickey AM, Smith S, Kerkvliet JG, Taraska JW, Hoppe AD.

Nat Commun. 2018 Jan 29;9(1):419. doi: 10.1038/s41467-018-02818-8.

32.

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Deeg HJ, Stevens EA, Salit RB, Ermoian RP, Fang M, Gyurkocza B, Sorror ML, Fatobene G, Baumgart J, Burroughs LM, Delaney C, Doney K, Egan DN, Flowers MED, Milano F, Radich JP, Scott BL, Sickle EJ, Wood BL, Yeung C, Storer BE.

Biol Blood Marrow Transplant. 2018 May;24(5):956-963. doi: 10.1016/j.bbmt.2017.12.785. Epub 2017 Dec 20.

33.

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.

Walter RB, Othus M, Orlowski KF, McDaniel EN, Scott BL, Becker PS, Percival MM, Hendrie PC, Medeiros BC, Chiarella MT, Louie AC, Estey EH.

Haematologica. 2018 Mar;103(3):e106-e109. doi: 10.3324/haematol.2017.182642. Epub 2017 Dec 14. No abstract available.

34.

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

Samuelson Bannow BT, Salit RB, Storer BE, Stevens EA, Wu D, Yeung C, Fang M, Petersdorf EW, Linenberger ML, Woo J, Sorror ML, Doney K, Sandmaier BM, Deeg HJ, Scott BL.

Biol Blood Marrow Transplant. 2018 Feb;24(2):386-392. doi: 10.1016/j.bbmt.2017.09.016. Epub 2017 Sep 29.

35.

Revisiting the bis(dimethylamido) metallocene complexes of thorium and uranium: improved syntheses, structure, spectroscopy, and redox energetics of (C5Me5)2An(NMe2)2 (An = Th, U).

Erickson KA, Kagan BD, Scott BL, Morris DE, Kiplinger JL.

Dalton Trans. 2017 Aug 29;46(34):11208-11213. doi: 10.1039/c7dt02373a.

PMID:
28795722
36.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352.

37.

Magnetic circular dichroism of UCl6- in the ligand-to-metal charge-transfer spectral region.

Gendron F, Fleischauer VE, Duignan TJ, Scott BL, Löble MW, Cary SK, Kozimor SA, Bolvin H, Neidig ML, Autschbach J.

Phys Chem Chem Phys. 2017 Jul 5;19(26):17300-17313. doi: 10.1039/c7cp02572f.

PMID:
28642944
38.

Covalency in Americium(III) Hexachloride.

Cross JN, Su J, Batista ER, Cary SK, Evans WJ, Kozimor SA, Mocko V, Scott BL, Stein BW, Windorff CJ, Yang P.

J Am Chem Soc. 2017 Jun 28;139(25):8667-8677. doi: 10.1021/jacs.7b03755. Epub 2017 Jun 14.

PMID:
28613849
39.

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Festuccia M, Baker K, Gooley TA, Sandmaier BM, Deeg HJ, Scott BL.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1509-1514. doi: 10.1016/j.bbmt.2017.05.034. Epub 2017 Jun 30.

40.

Multiple Unilateral Skull Base Defects in a Child With Conductive Hearing Loss.

Scott BL, Wick CC, Shah GB, Booth TN, Kutz JW Jr.

Otol Neurotol. 2017 Aug;38(7):e209-e210. doi: 10.1097/MAO.0000000000001473. No abstract available.

PMID:
28591001
41.

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.

Halpern AB, Othus M, Huebner EM, Buckley SA, Pogosova-Agadjanyan EL, Orlowski KF, Scott BL, Becker PS, Hendrie PC, Chen TL, Percival MM, Estey EH, Stirewalt DL, Walter RB.

Leukemia. 2017 Dec;31(12):2560-2567. doi: 10.1038/leu.2017.165. Epub 2017 May 30.

42.

Endocrine Mucin-Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery.

Scott BL, Anyanwu CO, Vandergriff T, Nijhawan RI.

Dermatol Surg. 2017 Dec;43(12):1498-1500. doi: 10.1097/DSS.0000000000001138. No abstract available.

PMID:
28394861
43.

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME.

J Clin Oncol. 2017 Apr 10;35(11):1154-1161. doi: 10.1200/JCO.2016.70.7091. Epub 2017 Feb 13.

44.

Identification of the Formal +2 Oxidation State of Plutonium: Synthesis and Characterization of {PuII[C5H3(SiMe3)2]3}<sup/>.

Windorff CJ, Chen GP, Cross JN, Evans WJ, Furche F, Gaunt AJ, Janicke MT, Kozimor SA, Scott BL.

J Am Chem Soc. 2017 Mar 22;139(11):3970-3973. doi: 10.1021/jacs.7b00706. Epub 2017 Mar 13.

PMID:
28235179
45.

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.

Woo J, Howard NP, Storer BE, Fang M, Yeung CC, Scott BL, Deeg HJ.

Haematologica. 2017 Jun;102(6):e216-e218. doi: 10.3324/haematol.2016.162909. Epub 2017 Feb 16. No abstract available.

46.

Why Does Alkylation of the N-H Functionality within M/NH Bifunctional Noyori-Type Catalysts Lead to Turnover?

Dub PA, Scott BL, Gordon JC.

J Am Chem Soc. 2017 Jan 25;139(3):1245-1260. doi: 10.1021/jacs.6b11666. Epub 2017 Jan 3.

PMID:
28045260
47.

Development of Basal Cell Carcinoma With Squamous Differentiation During Vismodegib Treatment.

Feigenbaum L, Scott BL, Moye MS, Nijhawan RI.

Dermatol Surg. 2017 Jul;43(7):989-991. doi: 10.1097/DSS.0000000000001012. No abstract available.

PMID:
28002101
48.

An Energetic Triazolo-1,2,4-Triazine and its N-Oxide.

Piercey DG, Chavez DE, Scott BL, Imler GH, Parrish DA.

Angew Chem Int Ed Engl. 2016 Dec 5;55(49):15315-15318. doi: 10.1002/anie.201608723. Epub 2016 Nov 9.

PMID:
27862728
49.

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.

Woo J, Deeg HJ, Storer B, Yeung C, Fang M, Mielcarek M, Scott BL.

Biol Blood Marrow Transplant. 2017 Jan;23(1):176-179. doi: 10.1016/j.bbmt.2016.10.016. Epub 2016 Oct 24.

50.

Comparing the 2,2'-Biphenylenedithiophosphinate Binding of Americium with Neodymium and Europium.

Cross JN, Macor JA, Bertke JA, Ferrier MG, Girolami GS, Kozimor SA, Maassen JR, Scott BL, Shuh DK, Stein BW, Stieber SC.

Angew Chem Int Ed Engl. 2016 Oct 4;55(41):12755-9. doi: 10.1002/anie.201606367. Epub 2016 Sep 15.

Supplemental Content

Loading ...
Support Center